Evidence map›Paper›PMID 35646724›Full record

ReviewFrontiers in cellular and infection microbiology2022

Forward Genetics in Apicomplexa Biology: The Host Side of the Story.

Juan C Sánchez-Arcila, Kirk D C Jensen

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Juan C Sánchez-ArcilaDepartment of Molecular and Cell Biology, University of California Merced, Merced, CA, United States.
Kirk D C JensenDepartment of Molecular and Cell Biology, University of California Merced, Merced, CA, United States.
University of California, Merced · US

Funding

New requirements for immunity to parasitic pathogens - when vaccines work and why they failR01AI137126 · NIAID · UNIVERSITY OF CALIFORNIA, MERCED · PI JENSEN, KIRK DAVID CHRISTIAN · 2018 to 2022
$2.0M
Using the Collaborative Cross to Discover New Requirments for Vaccine-Induced Immunity to T. gondiiR21AI145403 · NIAID · UNIVERSITY OF CALIFORNIA, MERCED · PI JENSEN, KIRK DAVID CHRISTIAN · 2019 to 2020
$413k
NIAID NIH HHS R01 AI137126NIAID NIH HHS R21 AI145403
6 · The paper itself

Abstract

Forward genetic approaches have been widely used in parasitology and have proven their power to reveal the complexities of host-parasite interactions in an unbiased fashion. Many aspects of the parasite's biology, including the identification of virulence factors, replication determinants, antibiotic resistance genes, and other factors required for parasitic life, have been discovered using such strategies. Forward genetic approaches have also been employed to understand host resistance mechanisms to parasitic infection. Here, we will introduce and review all forward genetic approaches that have been used to identify host factors involved with Apicomplexa infections, which include classical genetic screens and QTL mapping, GWAS, ENU mutagenesis, overexpression, RNAi and CRISPR-Cas9 library screens. Collectively, these screens have improved our understanding of host resistance mechanisms, immune regulation, vaccine and drug designs for Apicomplexa parasites. We will also discuss how recent advances in molecular genetics give present opportunities to further explore host-parasite relationships.

Indexed as

ApicomplexaGenetic TestingBiologyHost-Parasite InteractionsMutagenesisapicomplexaclassical geneticsCRISPR-Cas9ENUforward genetic screenshost immunityQTLRNAi

Identifiers

PMID35646724
PMCPMC9133346
OpenAlexW4280516142

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.